Professionals
Related Practices
Overview
Pharmaceutical and medical products manufacturers are of one of the most highly regulated and closely scrutinized industries today. The field is marked by exciting research and development opportunities and life-changing medical advances, but also by escalating litigation or other legal needs.
Dykema has earned a place as counsel to the industry by consistently delivering business-focused, creative legal guidance and aggressive representation of the tough issues facing the industry. When our clients tell us what they need, describe their situations and explain their goals, we listen. We respond by building a defense or business strategy that addresses the demands of each unique situation and working closely with the client every step of the way. In litigation matters, we always prepare for trial, even though the majority of cases will be resolved out of the courtroom.
This dedication to client service and attention to detail has made Dykema’s Pharmaceuticals and Medical Products Practice Group the choice of some of the most prominent members of the field. We provide counsel to a wide range of clients including manufacturers of prescription drugs, OTC drugs, device manufacturers and medical facilities. We have a long history with the industry, providing a legal and a scientific perspective that is crucial when it comes to high-profile matters that may impact a company’s reputation and bottom line.
The wide range of services Dykema has provided to pharmaceutical and medical products manufacturers includes:
- Commercial litigation
- Product liability defense
- Mergers and acquisitions (including cross-border)
- Equity and debt financings
- Federal and state government-related funding
- Intellectual Property and IP litigation
- Contracts
- Licensing
- Corporate
- Corporate governance
- Securities
- Compliance
- Government relations
- Tax
- Distribution, manufacturing and supply agreements
News
- July 27, 2015
- December 16, 2014
- March 21, 2014
- January 15, 2014
- September 18, 2013
- February 20, 2013
Press Releases
- September 10, 2018
- September 7, 2018
- February 5, 2018
- January 25, 2018
- January 20, 2017
- January 13, 2017
- October 6, 2016
- August 18, 2015
- August 3, 2015
- February 5, 2014
- January 28, 2014
- January 14, 2014
Publications
- "The Plaintiff Bar's Latest Attack on Generic Drug Manufacturers: How a new FDA Rule Could Dismantle Recent Legal Victories"Pharmaceutical Compliance MonitorDecember 10, 2014
- "Proposed FDA Food-Safety Rules May Create Strains on Importer-Supplier Relationships"American Bar Association Products Liability News & DevelopmentsSeptember 2013
Events & Speaking Engagements
- September 24, 2020